Collaborate 2 Cure
Events

Current Topic: Immunotherapy, Cancer and Beyond

Collaborate2Cure events are held every Thursday from 4 – 6 pm. Check the calendar below for more info on upcoming events.

September 29, 2016
Introduction to Collaborate2Cure – Wayne Carter, DVM, PhD, DACVIM
Advancing Immunotherapy in the Kansas City Region: Chimeric Antigen Receptors Targeting Cancer and Beyond – Doug Myers, MD
Learn more »

October 6, 2016
Novel Approaches to the Design of Chimeric Antigen Receptors – Thomas Yankee, PharmD, PhD
Incorporation of NKG2D Signaling Into Cancer Immunotherapy – Mary Markiewicz, PhD
Learn more »

October 13, 2016
Biomaterials for Cell Delivery in Animal Models – Gabriel Converse, PhD
Hyperthermia: More Than an Adjuvant to Cancer Therapies – Stefan Bossmann, PhD
Learn more »

October 20, 2016
Antigen-targeted Therapy for Head and Neck Cancer – Sufi Thomas, PhD
Breezio Introduction – Karen McCord
Learn more »

October 27, 2016
inCVAX: An in situ Autologous Cancer Vaccine – Joseph Raker, PhD
Practical Considerations for Translation of CAR-T Cell Therapies to the Market – Sara Mary Hall
Learn more »

November 3, 2016 – Kansas City One Health Day
Treating Cancer with Ex Vivo-Activated Cancer Neoantigen-Specific Effector T Cells – Tammie Wahaus
Howling at the Moonshot – Carolyn Henry DVM, MS, DACVIM
Learn more »

November 10, 2016
Engineering Regulatory T Cells for the Treatment of Graft-Versus-Host Disease – Thomas Yankee, PharmD, PhD
Immunotherapy of Osteosarcoma – Laura Simon Treml, VMD, PhD
Learn more »

November 17, 2016
Immune Monitoring Toolkit for Canine Immunotherapy Trials – Jeffrey N. Bryan, DVM, MS, PhD, DACVIM(Oncology)
Learn more »

December 1, 2016
Quest for Developing Novel Immunological Assays for Cancer Immunotherapy – Francisco Martinez Becerra , PhD
Isolation and Molecular Profiling of Circulating Tumor Cells with Divergent Phenotypes -Maggie Witek, PhD
Learn more »

December 8, 2016
Tumor In a Dish: Novel Approach for Personalized Medicine – Shrikant Anant, PhD
Translating Research into Clinical Practice in Hepatocellular Cancer – Kevin Staveley-O’Carroll, MD, PhD
Learn more »

December 15, 2016
The Role of Complex Gut Microbiota in the Susceptibility to Colorectal Cancer – James M. Amos-Landgraf, PhD
Tolerance Induction for Organ Transplants by Myeloid Progenitor Cells – Jos Domen, PhD
Learn more »